Literature DB >> 18326959

Can ischemic stroke be caused by acute reduction of blood pressure in the acute phase of cardiovascular disease?

Satoshi Hoshide1, Kazuo Eguchi, Joji Ishikawa, Mitsunobu Murata, Takaaki Katsuki, Takeshi Mitsuhashi, Kazuyuki Shimada, Kazuomi Kario.   

Abstract

Acute-phase cardiovascular disease (CVD) frequently presents with markedly elevated blood pressure (BP) levels and often requires fairly rapid lowering of BP. On the other hand, aggressive lowering of systemic BP to the point that the cerebral BP decreases below a certain threshold may result in ischemic stroke. The authors retrospectively studied 192 consecutive patients with CVD who had markedly elevated BP and end-organ damage. Ischemic stroke was noted in 12 of these patients during BP-lowering therapy. The incidence of ischemic stroke did not differ significantly between a standard BP-lowering group, in which the target BP reduction was within the parameters of the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure guidelines, and a rapid BP-lowering group, in which the target BP was below these guidelines (7.1% vs 2.6%, respectively; P=.27, not significant). In stepwise multiple regression analysis, diabetes mellitus (beta=0.203, P=.008) and acute pulmonary edema (beta=0.228, P=.003) remained significant factors associated with the incidence of stroke. Thus, acute pulmonary edema and diabetes were the most important factors related to ischemic stroke during BP reduction in patients with marked elevations of BP regardless of the rapidity of BP lowering.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18326959      PMCID: PMC8110073          DOI: 10.1111/j.1751-7176.2008.07339.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  26 in total

1.  Early assessment and in-hospital management of patients with acute myocardial infarction at increased risk for adverse outcomes: a nationwide perspective of current clinical practice. The National Registry of Myocardial Infarction (NRMI-2) Participants.

Authors:  R C Becker; M Burns; J M Gore; F A Spencer; S P Ball; W French; C Lambrew; L Bowlby; J Hilbe; W J Rogers
Journal:  Am Heart J       Date:  1998-05       Impact factor: 4.749

2.  Plasma fibrinogen: a new factor of the metabolic syndrome. A population-based study.

Authors:  G Imperatore; G Riccardi; C Iovine; A A Rivellese; O Vaccaro
Journal:  Diabetes Care       Date:  1998-04       Impact factor: 19.112

Review 3.  Cerebral ischaemia and stroke as side effects of antihypertensive treatment; special danger in the elderly. A review of the cases reported in the literature.

Authors:  P A Jansen; B P Schulte; F W Gribnau
Journal:  Neth J Med       Date:  1987-04       Impact factor: 1.422

4.  A computed tomographic guide to the identification of cerebral vascular territories.

Authors:  H Damasio
Journal:  Arch Neurol       Date:  1983-03

Review 5.  The diagnosis and management of hypertensive crises.

Authors:  J Varon; P E Marik
Journal:  Chest       Date:  2000-07       Impact factor: 9.410

6.  Chronically impaired autoregulation of cerebral blood flow in long-term diabetics.

Authors:  N Bentsen; B Larsen; N A Lassen
Journal:  Stroke       Date:  1975 Sep-Oct       Impact factor: 7.914

7.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

Review 8.  Cardiogenic brain embolism. Cerebral Embolism Task Force.

Authors: 
Journal:  Arch Neurol       Date:  1986-01

9.  Frequency and embolic potential of left ventricular thrombus in dilated cardiomyopathy: assessment by 2-dimensional echocardiography.

Authors:  J S Gottdiener; J A Gay; L VanVoorhees; R DiBianco; R D Fletcher
Journal:  Am J Cardiol       Date:  1983-12-01       Impact factor: 2.778

Review 10.  Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1994-02-05       Impact factor: 79.321

View more
  1 in total

1.  Treatment of hypertension in the inpatient setting: use of intravenous labetalol and hydralazine.

Authors:  Alan B Weder; Steven Erickson
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-01       Impact factor: 3.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.